Literature DB >> 29038269

A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Karlijn van Loon1, Anne F Voor In 't Holt1, Margreet C Vos2.   

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) are major health care-associated pathogens and responsible for hospital outbreaks worldwide. To prevent a further increase in CRE infections and to improve infection prevention strategies, it is important to summarize the current knowledge about CRE infection prevention in hospital settings. This systematic review aimed to identify risk factors for CRE acquisition among hospitalized patients. In addition, we summarized the environmental sources/reservoirs and the most successful infection prevention strategies related to CRE. A total of 3,983 potentially relevant articles were identified and screened. Finally, we included 162 studies in the systematic review, of which 69 studies regarding risk factors for CRE acquisition were included in the random-effects meta-analysis studies. The meta-analyses regarding risk factors for CRE acquisition showed that the use of medical devices generated the highest pooled estimate (odds ratio [OR] = 5.09; 95% confidence interval [CI] = 3.38 to 7.67), followed by carbapenem use (OR = 4.71; 95% CI = 3.54 to 6.26). To control hospital outbreaks, bundled interventions, including the use of barrier/contact precautions for patients colonized or infected with CRE, are needed. In addition, it is necessary to optimize the therapeutic approach, which is an important message to infectious disease specialists, who need to be actively involved in a timely manner in the treatment of patients with known CRE infections or suspected carriers of CRE.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Enterobacteriaceae; carbapenem; meta-analysis; resistance; risk factors; systematic review

Mesh:

Substances:

Year:  2017        PMID: 29038269      PMCID: PMC5740327          DOI: 10.1128/AAC.01730-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  177 in total

1.  The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting.

Authors:  Alexandre R Marra; Silvana Maria de Almeida; Luci Correa; Moacyr Silva; Marinês Dalla Valle Martino; Cláudia Vallone Silva; Ruy Guilherme Rodrigues Cal; Michael B Edmond; Oscar Fernando Pavão dos Santos
Journal:  Am J Infect Control       Date:  2008-11-04       Impact factor: 2.918

2.  Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.

Authors:  K Poole; R George; V Decraene; K Shankar; J Cawthorne; N Savage; W Welfare; A Dodgson
Journal:  J Hosp Infect       Date:  2016-06-29       Impact factor: 3.926

3.  Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.

Authors:  G B Orsi; A Bencardino; A Vena; A Carattoli; C Venditti; M Falcone; A Giordano; M Venditti
Journal:  Infection       Date:  2012-10-16       Impact factor: 3.553

4.  Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland.

Authors:  Dearbháile Morris; Fiona Boyle; Carol Morris; Iris Condon; Anne-Sophie Delannoy-Vieillard; Lorraine Power; Aliya Khan; Margaret Morris-Downes; Cathriona Finnegan; James Powell; Regina Monahan; Karen Burns; Nuala O'Connell; Liz Boyle; Alan O'Gorman; Hilary Humphreys; Sylvain Brisse; Jane Turton; Neil Woodford; Martin Cormican
Journal:  J Antimicrob Chemother       Date:  2012-06-28       Impact factor: 5.790

5.  Investigation of the first outbreak of OXA-48-producing Klebsiella pneumoniae in Ireland.

Authors:  C Wrenn; D O'Brien; D Keating; C Roche; L Rose; A Ronayne; L Fenelon; S Fitzgerald; B Crowley; K Schaffer
Journal:  J Hosp Infect       Date:  2014-03-25       Impact factor: 3.926

6.  Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.

Authors:  Dror Marchaim; Shiri Navon-Venezia; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

7.  Successful containment and infection control of a Carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital.

Authors:  Paolo Gaibani; Rosaria Colombo; Milena Arghittu; Lisa Cariani; Simone Ambretti; Gloria Bua; Donatella Lombardo; Maria Paola Landini; Erminio Torresani; Vittorio Sambri
Journal:  New Microbiol       Date:  2014-01-15       Impact factor: 2.479

8.  Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore.

Authors:  Moi Lin Ling; Yong Ming Tee; Soong Geck Tan; Ismawati M Amin; Kue Bien How; Kwee Yuen Tan; Lai Chee Lee
Journal:  Antimicrob Resist Infect Control       Date:  2015-06-23       Impact factor: 4.887

9.  Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.

Authors:  Irmak Baran; Neriman Aksu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-04-06       Impact factor: 3.944

10.  Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea.

Authors:  Hyo Jin Lee; Jae Ki Choi; Sung Yeon Cho; Si Hyun Kim; Sun Hee Park; Su Mi Choi; Dong Gun Lee; Jung Hyun Choi; Jin Hong Yoo
Journal:  Infect Chemother       Date:  2016-09-08
View more
  59 in total

1.  Characterization of 2 Klebsiella pneumoniae carbapenemase-producing Enterobacterales isolated from canine rectal swabs.

Authors:  Stephen D Cole; Shelley C Rankin
Journal:  J Vet Diagn Invest       Date:  2021-12-21       Impact factor: 1.279

2.  A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems.

Authors:  Evangelos J Giamarellos-Bourboulis; Antigone Kotsaki; Christina Routsi; Elena Graziano; Elda Righi; Matteo Bassetti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-06       Impact factor: 3.267

3.  Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017.

Authors:  Krystyna M Kazmierczak; James A Karlowsky; Boudewijn L M de Jonge; Gregory G Stone; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

Review 4.  Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.

Authors:  Hsin-Yu Chen; Shio-Shin Jean; Yu-Lin Lee; Min-Chi Lu; Wen-Chien Ko; Po-Yu Liu; Po-Ren Hsueh
Journal:  Front Cell Infect Microbiol       Date:  2021-04-23       Impact factor: 5.293

5.  Prior Antibiotic Therapy and the Onset of Healthcare-Associated Infections Sustained by Multidrug-Resistant Klebsiella pneumoniae in Intensive Care Unit Patients: A Nested Case-Control Study.

Authors:  Giuseppe Migliara; Valentina Baccolini; Claudia Isonne; Sara Cianfanelli; Carolina Di Paolo; Annamaria Mele; Lorenza Lia; Angelo Nardi; Carla Salerno; Susanna Caminada; Vittoria Cammalleri; Francesco Alessandri; Guglielmo Tellan; Giancarlo Ceccarelli; Mario Venditti; Francesco Pugliese; Carolina Marzuillo; Corrado De Vito; Maria De Giusti; Paolo Villari
Journal:  Antibiotics (Basel)       Date:  2021-03-15

6.  Design of Rapid Detection System for Five Major Carbapenemase Families (bla KPC, bla NDM, bla VIM, bla IMP and bla OXA-48-Like) by Colorimetric Loop-Mediated Isothermal Amplification.

Authors:  Wenjuan Feng; Siqiang Niu; Yanbin Chang; Xiaojiong Jia; Shifeng Huang; Ping Yang
Journal:  Infect Drug Resist       Date:  2021-05-24       Impact factor: 4.003

7.  Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.

Authors:  Rima Moghnieh; Dania Abdallah; Marwa Jadayel; Wael Zorkot; Hassan El Masri; Marie Joe Dib; Tasnim Omar; Loubna Sinno; Rawad Lakkis; Tamima Jisr
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

8.  Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.

Authors:  Qun Lin; Yue Wang; Jing Yu; Shusheng Li; Yicheng Zhang; Hui Wang; Xiaoquan Lai; Dong Liu; Liyan Mao; Ying Luo; Guoxing Tang; Zhongju Chen; Ziyong Sun
Journal:  BMC Infect Dis       Date:  2021-07-02       Impact factor: 3.090

9.  Epidemiology and Transmission of Carbapenemase-Producing Enterobacteriaceae in a Health Care Network of an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term-Care Facilities in Singapore.

Authors:  Aung-Hein Aung; Kala Kanagasabai; Jocelyn Koh; Pei-Yun Hon; Brenda Ang; David Lye; Swaine L Chen; Angela Chow
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

10.  Implementation of an antimicrobial stewardship programme and reduction in carbapenemase-producing Enterobacterales in an Australian local health district.

Authors:  Kimberly Cipko; Jose Cuenca; Erica Wales; Joanna Harris; Stuart Bond; Peter Newton; Spiros Miyakis
Journal:  JAC Antimicrob Resist       Date:  2020-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.